Establishment and characterization of a MALT lymphoma cell line carrying an API2‐MALT1 translocation

MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been no lymphoma cell lines carrying API2‐MALT1 translocation reported to date. We established a novel lymphoma cell line named BMA19, carrying t...

Full description

Saved in:
Bibliographic Details
Published in:Genes chromosomes & cancer Vol. 59; no. 9; pp. 517 - 524
Main Authors: Izumi, Kiyotaka, Nishikori, Momoko, Yuan, Hepei, Otsuka, Yasuyuki, Nakao, Kensuke, Takaori‐Kondo, Akifumi
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 01-09-2020
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been no lymphoma cell lines carrying API2‐MALT1 translocation reported to date. We established a novel lymphoma cell line named BMA19, carrying the API2‐MALT1 translocation from a patient with histologic transformation of intestinal MALT lymphoma. The cells were suggested to carry API2‐MALT1 and MYC‐IGH translocations by chromosomal analysis, and these translocations were confirmed by polymerase chain reaction analysis. The expression of MYC was shown to be enhanced as a result of the MYC‐IGH translocation, and it is considered to have played a role in the histologic transformation of MALT lymphoma. Whole exome sequencing of BMA19 identified several nucleotide variations in genes reported to be mutated in previous studies of marginal zone lymphomas. The MALT1 inhibitor MI‐2 specifically decreased cell growth, and the BMA19 cell line was suggested to be still dependent on the API2‐MALT1 signal. Subtractive microarray analysis showed that one of the earliest events resulting from MALT1 inhibition is increased susceptibility to endoplasmic reticulum stress‐induced apoptosis. The BMA19 cell line is considered to conserve the biological properties of MALT lymphoma and is expected to be a valuable tool for research into the pathogenesis of MALT lymphoma with an API2‐MALT1 translocation.
AbstractList MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been no lymphoma cell lines carrying API2‐MALT1 translocation reported to date. We established a novel lymphoma cell line named BMA19, carrying the API2‐MALT1 translocation from a patient with histologic transformation of intestinal MALT lymphoma. The cells were suggested to carry API2‐MALT1 and MYC‐IGH translocations by chromosomal analysis, and these translocations were confirmed by polymerase chain reaction analysis. The expression of MYC was shown to be enhanced as a result of the MYC‐IGH translocation, and it is considered to have played a role in the histologic transformation of MALT lymphoma. Whole exome sequencing of BMA19 identified several nucleotide variations in genes reported to be mutated in previous studies of marginal zone lymphomas. The MALT1 inhibitor MI‐2 specifically decreased cell growth, and the BMA19 cell line was suggested to be still dependent on the API2‐MALT1 signal. Subtractive microarray analysis showed that one of the earliest events resulting from MALT1 inhibition is increased susceptibility to endoplasmic reticulum stress‐induced apoptosis. The BMA19 cell line is considered to conserve the biological properties of MALT lymphoma and is expected to be a valuable tool for research into the pathogenesis of MALT lymphoma with an API2‐MALT1 translocation.
MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been no lymphoma cell lines carrying API2‐MALT1 translocation reported to date. We established a novel lymphoma cell line named BMA19, carrying the API2‐MALT1 translocation from a patient with histologic transformation of intestinal MALT lymphoma. The cells were suggested to carry API2‐MALT1 and MYC‐IGH translocations by chromosomal analysis, and these translocations were confirmed by polymerase chain reaction analysis. The expression of MYC was shown to be enhanced as a result of the MYC‐IGH translocation, and it is considered to have played a role in the histologic transformation of MALT lymphoma. Whole exome sequencing of BMA19 identified several nucleotide variations in genes reported to be mutated in previous studies of marginal zone lymphomas. The MALT1 inhibitor MI‐2 specifically decreased cell growth, and the BMA19 cell line was suggested to be still dependent on the API2‐MALT1 signal. Subtractive microarray analysis showed that one of the earliest events resulting from MALT1 inhibition is increased susceptibility to endoplasmic reticulum stress‐induced apoptosis. The BMA19 cell line is considered to conserve the biological properties of MALT lymphoma and is expected to be a valuable tool for research into the pathogenesis of MALT lymphoma with an API2‐MALT1 translocation.
Author Otsuka, Yasuyuki
Nakao, Kensuke
Takaori‐Kondo, Akifumi
Izumi, Kiyotaka
Nishikori, Momoko
Yuan, Hepei
Author_xml – sequence: 1
  givenname: Kiyotaka
  surname: Izumi
  fullname: Izumi, Kiyotaka
  organization: Graduate School of Medicine, Kyoto University
– sequence: 2
  givenname: Momoko
  orcidid: 0000-0003-4171-2162
  surname: Nishikori
  fullname: Nishikori, Momoko
  email: nishikor@kuhp.kyoto-u.ac.jp
  organization: Graduate School of Medicine, Kyoto University
– sequence: 3
  givenname: Hepei
  surname: Yuan
  fullname: Yuan, Hepei
  organization: Graduate School of Medicine, Kyoto University
– sequence: 4
  givenname: Yasuyuki
  surname: Otsuka
  fullname: Otsuka, Yasuyuki
  organization: Graduate School of Medicine, Kyoto University
– sequence: 5
  givenname: Kensuke
  surname: Nakao
  fullname: Nakao, Kensuke
  organization: Graduate School of Medicine, Kyoto University
– sequence: 6
  givenname: Akifumi
  surname: Takaori‐Kondo
  fullname: Takaori‐Kondo, Akifumi
  organization: Graduate School of Medicine, Kyoto University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32348592$$D View this record in MEDLINE/PubMed
BookMark eNp1kLtOwzAUhi1URC8w8ALIEgsMbR3HzmWsqlIqFcHQ3TpxnDZVYhc7FSoTj8Az8iS4FxiQGI7OGb7z6dffRS1ttELoOiCDgBA6XEo5oDTh_Ax1ApImfUoj1trfjPubx23UdW5NCInClF-gdkhDlvCUdlAxcQ1kVelWtdINBp1juQILslG2fIemNBqbAgN-Gs0XuNrVm5WpAUtVVbgqtcISrN2Veulf8ehlRr8-PvdogBsL2lVGHhyX6LyAyqmr0-6hxcNkMX7sz5-ns_Fo3pcsSHlfKpoDT4uE5hnPU1BxJqM4plzGPnnBOeSMxSSNgDAVZYRllGd5BtIPyYuwh-6O2o01r1vlGlGXbp8VtDJbJ2iYRgkPWRB49PYPujZbq304QX0WxpKIx566P1LSGuesKsTGljXYnQiI2HcvfPfi0L1nb07GbVar_Jf8KdsDwyPwVlZq979JTMfjo_Ib4VSP7w
CitedBy_id crossref_primary_10_3389_fonc_2022_1060496
crossref_primary_10_3389_fonc_2023_1115943
crossref_primary_10_2147_JIR_S319023
Cites_doi 10.1111/j.1349-7006.2002.tb01306.x
10.3324/haematol.2018.214957
10.1111/j.1349-7006.2003.tb01518.x
10.1038/nrc3748
10.1158/0008-5472.CAN-17-2485
10.1158/1078-0432.CCR-15-2296
10.1016/S0002-9440(10)64157-0
10.1016/S0002-9440(10)64988-7
10.1097/MOH.0000000000000051
10.1016/j.molimm.2020.01.006
10.1016/j.semcancer.2013.11.005
10.1182/blood.V88.3.985.bloodjournal883985
10.1046/j.1365-2141.2003.04035.x
10.1126/science.1198946
10.1038/onc.2014.186
10.1182/blood.V95.3.802.003k19_802_806
10.1016/S1074-7613(03)00029-3
10.1038/nm.3884
10.1016/S0002-9440(10)65012-2
10.1007/s12185-019-02810-y
10.1038/nprot.2008.211
10.1101/gad.871201
10.1182/blood-2002-11-3502
10.1084/jem.20120904
10.1074/jbc.271.10.5513
10.1016/S0002-9440(10)64948-6
10.1016/j.ccr.2012.11.003
10.1002/(SICI)1096-9896(199704)181:4<381::AID-PATH787>3.0.CO;2-I
10.1371/journal.pone.0083244
10.1038/nrc1409
10.1074/jbc.M009984200
10.1093/nar/gkq603
10.1093/nar/gkn923
ContentType Journal Article
Copyright 2020 Wiley Periodicals, Inc.
Copyright_xml – notice: 2020 Wiley Periodicals, Inc.
DBID NPM
AAYXX
CITATION
7QP
7TM
7TO
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1002/gcc.22855
DatabaseName PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList
PubMed
CrossRef
Genetics Abstracts
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-2264
EndPage 524
ExternalDocumentID 10_1002_gcc_22855
32348592
GCC22855
Genre article
Journal Article
GrantInformation_xml – fundername: Japan Society for the Promotion of Science
  funderid: 18K08324
– fundername: Japan Society for the Promotion of Science
  grantid: 18K08324
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEFU
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GLUZI
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6P
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
V8K
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWO
WXI
WXSBR
XG1
XPP
XV2
ZGI
ZZTAW
~IA
~WT
NPM
AAMNL
AAYXX
CITATION
7QP
7TM
7TO
8FD
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c4195-ce2da59f82db5d9ae7bc67725c7639f55ad447096a04e6b04b25bdbacdba0df3
IEDL.DBID 33P
ISSN 1045-2257
IngestDate Fri Aug 16 05:59:20 EDT 2024
Mon Nov 18 21:24:12 EST 2024
Thu Nov 21 23:59:50 EST 2024
Sat Sep 28 08:27:49 EDT 2024
Sat Aug 24 01:06:30 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords MALT lymphoma
microarray analysis
API2-MALT1
cell line
MALT1 inhibitor
Language English
License 2020 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4195-ce2da59f82db5d9ae7bc67725c7639f55ad447096a04e6b04b25bdbacdba0df3
Notes Funding information
Japan Society for the Promotion of Science, Grant/Award Number: 18K08324
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4171-2162
PMID 32348592
PQID 2419448657
PQPubID 866394
PageCount 8
ParticipantIDs proquest_miscellaneous_2396853411
proquest_journals_2419448657
crossref_primary_10_1002_gcc_22855
pubmed_primary_32348592
wiley_primary_10_1002_gcc_22855_GCC22855
PublicationCentury 2000
PublicationDate September 2020
PublicationDateYYYYMMDD 2020-09-01
PublicationDate_xml – month: 09
  year: 2020
  text: September 2020
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Hoboken
PublicationTitle Genes chromosomes & cancer
PublicationTitleAlternate Genes Chromosomes Cancer
PublicationYear 2020
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2015; 34
2010; 38
2004; 4
2019; 104
2000; 95
2014; 24
2003; 18
1997; 181
2000; 156
2003; 94
2013; 8
2011; 331
2014; 21
2012; 209
2001; 276
2002; 161
2017; 77
1997; 57
2015; 21
1996; 271
2014; 14
2020; 111
2001; 15
2002; 93
2009; 4
2003; 102
2012; 22
2020; 119
2009; 37
2003; 120
1996; 88
2016; 22
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_24_1
Ott G (e_1_2_8_27_1) 1997; 57
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – volume: 21
  start-page: 309
  issue: 4
  year: 2014
  end-page: 319
  article-title: The origin and targeting of mucosa‐associated lymphoid tissue lymphomas
  publication-title: Curr Opin Hematol
– volume: 77
  start-page: 7038
  issue: 24
  year: 2017
  end-page: 7048
  article-title: MALT1 inhibition is efficacious in both naive and ibrutinib‐resistant chronic lymphocytic leukemia
  publication-title: Cancer Res
– volume: 21
  start-page: 922
  issue: 8
  year: 2015
  end-page: 926
  article-title: Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
  publication-title: Nat Med
– volume: 4
  start-page: 44
  issue: 1
  year: 2009
  end-page: 57
  article-title: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
  publication-title: Nat Protoc
– volume: 119
  start-page: 35
  year: 2020
  end-page: 45
  article-title: EZH2 inhibitors restore epigenetically silenced CD58 expression in B‐cell lymphomas
  publication-title: Mol Immunol
– volume: 111
  start-page: 724
  issue: 5
  year: 2020
  end-page: 732
  article-title: Histologic transformation of t(11;18)‐positive MALT lymphoma presented with aberrant T‐cell marker expression
  publication-title: Int J Hematol
– volume: 4
  start-page: 644
  issue: 8
  year: 2004
  end-page: 653
  article-title: MALT lymphoma: from morphology to molecules
  publication-title: Nat Rev Cancer
– volume: 94
  start-page: 774
  issue: 9
  year: 2003
  end-page: 781
  article-title: Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B‐cell lymphoma
  publication-title: Cancer Sci
– volume: 93
  start-page: 677
  issue: 6
  year: 2002
  end-page: 684
  article-title: Clinicopathologic comparison between the API2‐MALT1 chimeric transcript‐positive and ‐negative gastric low‐grade B‐cell lymphoma of mucosa‐associated lymphoid tissue type
  publication-title: Jpn J Cancer Res
– volume: 34
  start-page: 2406
  issue: 18
  year: 2015
  end-page: 2409
  article-title: A common functional consequence of tumor‐derived mutations within c‐MYC
  publication-title: Oncogene
– volume: 22
  start-page: 3593
  issue: 14
  year: 2016
  end-page: 3605
  article-title: Clinical and biologic significance of MYC genetic mutations in de novo diffuse large B‐cell lymphoma
  publication-title: Clin Cancer Res
– volume: 38
  issue: 16
  year: 2010
  article-title: ANNOVAR: functional annotation of genetic variants from high‐throughput sequencing data
  publication-title: Nucleic Acids Res
– volume: 57
  start-page: 3944
  issue: 18
  year: 1997
  end-page: 3948
  article-title: The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low‐grade but not high‐grade malignant non‐Hodgkin's lymphomas of the mucosa‐associated lymphoid tissue (MALT‐) type
  publication-title: Cancer Res
– volume: 156
  start-page: 1433
  issue: 4
  year: 2000
  end-page: 1439
  article-title: The product of the t(11;18), an API2‐MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation
  publication-title: Am J Pathol
– volume: 14
  start-page: 502
  issue: 7
  year: 2014
  end-page: 509
  article-title: New PARP targets for cancer therapy
  publication-title: Nat Rev Cancer
– volume: 120
  start-page: 97
  issue: 1
  year: 2003
  end-page: 100
  article-title: High frequency of t(11;18) in gastric mucosa‐associated lymphoid tissue lymphomas in Taiwan, including one patient with high‐grade transformation
  publication-title: Br J Haematol
– volume: 18
  start-page: 301
  issue: 2
  year: 2003
  end-page: 312
  article-title: Regulation of marginal zone B cell development by MINT, a suppressor of notch/RBP‐J signaling pathway
  publication-title: Immunity
– volume: 271
  start-page: 5513
  issue: 10
  year: 1996
  end-page: 5518
  article-title: Functional analysis of Burkitt's lymphoma mutant c‐Myc proteins
  publication-title: J Biol Chem
– volume: 102
  start-page: 1012
  issue: 3
  year: 2003
  end-page: 1018
  article-title: Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma
  publication-title: Blood
– volume: 331
  start-page: 468
  issue: 6016
  year: 2011
  end-page: 472
  article-title: Cleavage of NIK by the API2‐MALT1 fusion oncoprotein leads to noncanonical NF‐kappaB activation
  publication-title: Science
– volume: 15
  start-page: 1140
  issue: 9
  year: 2001
  end-page: 1151
  article-title: Sharp, an inducible cofactor that integrates nuclear receptor repression and activation
  publication-title: Genes Dev
– volume: 181
  start-page: 381
  issue: 4
  year: 1997
  end-page: 386
  article-title: c‐myc gene abnormalities in mucosa‐associated lymphoid tissue (MALT) lymphomas
  publication-title: J Pathol
– volume: 8
  issue: 12
  year: 2013
  article-title: Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma
  publication-title: PLoS One
– volume: 88
  start-page: 985
  issue: 3
  year: 1996
  end-page: 994
  article-title: Application of long‐distance polymerase chain reaction to detection of junctional sequences created by chromosomal translocation in mature B‐cell neoplasms
  publication-title: Blood
– volume: 156
  start-page: 1183
  issue: 4
  year: 2000
  end-page: 1188
  article-title: Incidence and subtype specificity of API2‐MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas
  publication-title: Am J Pathol
– volume: 95
  start-page: 802
  issue: 3
  year: 2000
  end-page: 806
  article-title: Mucosa‐associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed
  publication-title: Blood
– volume: 209
  start-page: 1537
  issue: 9
  year: 2012
  end-page: 1551
  article-title: The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development
  publication-title: J Exp Med
– volume: 22
  start-page: 812
  issue: 6
  year: 2012
  end-page: 824
  article-title: MALT1 small molecule inhibitors specifically suppress ABC‐DLBCL in vitro and in vivo
  publication-title: Cancer Cell
– volume: 161
  start-page: 63
  issue: 1
  year: 2002
  end-page: 71
  article-title: Mucosa‐associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa‐associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways
  publication-title: Am J Pathol
– volume: 156
  start-page: 807
  issue: 3
  year: 2000
  end-page: 812
  article-title: API2‐MALT1 chimeric transcripts involved in mucosa‐associated lymphoid tissue type lymphoma predict heterogeneous products
  publication-title: Am J Pathol
– volume: 104
  start-page: e558
  issue: 12
  year: 2019
  end-page: e561
  article-title: Novel insights into the genetics and epigenetics of MALT lymphoma unveiled by next generation sequencing analyses
  publication-title: Haematologica
– volume: 24
  start-page: 33
  year: 2014
  end-page: 42
  article-title: Chronic inflammation and extra‐nodal marginal‐zone lymphomas of MALT‐type
  publication-title: Semin Cancer Biol
– volume: 276
  start-page: 19012
  issue: 22
  year: 2001
  end-page: 19019
  article-title: Bcl10 and MALT1, independent targets of chromosomal translocation in MALT lymphoma, cooperate in a novel NF‐kappa B signaling pathway
  publication-title: J Biol Chem
– volume: 37
  start-page: 1
  issue: 1
  year: 2009
  end-page: 13
  article-title: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
  publication-title: Nucleic Acids Res
– ident: e_1_2_8_10_1
  doi: 10.1111/j.1349-7006.2002.tb01306.x
– ident: e_1_2_8_20_1
  doi: 10.3324/haematol.2018.214957
– ident: e_1_2_8_12_1
  doi: 10.1111/j.1349-7006.2003.tb01518.x
– ident: e_1_2_8_24_1
  doi: 10.1038/nrc3748
– ident: e_1_2_8_34_1
  doi: 10.1158/0008-5472.CAN-17-2485
– ident: e_1_2_8_22_1
  doi: 10.1158/1078-0432.CCR-15-2296
– ident: e_1_2_8_7_1
  doi: 10.1016/S0002-9440(10)64157-0
– ident: e_1_2_8_30_1
  doi: 10.1016/S0002-9440(10)64988-7
– ident: e_1_2_8_4_1
  doi: 10.1097/MOH.0000000000000051
– ident: e_1_2_8_13_1
  doi: 10.1016/j.molimm.2020.01.006
– ident: e_1_2_8_3_1
  doi: 10.1016/j.semcancer.2013.11.005
– ident: e_1_2_8_11_1
  doi: 10.1182/blood.V88.3.985.bloodjournal883985
– ident: e_1_2_8_6_1
  doi: 10.1046/j.1365-2141.2003.04035.x
– ident: e_1_2_8_35_1
  doi: 10.1126/science.1198946
– ident: e_1_2_8_21_1
  doi: 10.1038/onc.2014.186
– ident: e_1_2_8_25_1
  doi: 10.1182/blood.V95.3.802.003k19_802_806
– ident: e_1_2_8_16_1
  doi: 10.1016/S1074-7613(03)00029-3
– ident: e_1_2_8_33_1
  doi: 10.1038/nm.3884
– volume: 57
  start-page: 3944
  issue: 18
  year: 1997
  ident: e_1_2_8_27_1
  article-title: The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low‐grade but not high‐grade malignant non‐Hodgkin's lymphomas of the mucosa‐associated lymphoid tissue (MALT‐) type
  publication-title: Cancer Res
  contributor:
    fullname: Ott G
– ident: e_1_2_8_28_1
  doi: 10.1016/S0002-9440(10)65012-2
– ident: e_1_2_8_8_1
  doi: 10.1007/s12185-019-02810-y
– ident: e_1_2_8_14_1
  doi: 10.1038/nprot.2008.211
– ident: e_1_2_8_17_1
  doi: 10.1101/gad.871201
– ident: e_1_2_8_31_1
  doi: 10.1182/blood-2002-11-3502
– ident: e_1_2_8_18_1
  doi: 10.1084/jem.20120904
– ident: e_1_2_8_23_1
  doi: 10.1074/jbc.271.10.5513
– ident: e_1_2_8_29_1
  doi: 10.1016/S0002-9440(10)64948-6
– ident: e_1_2_8_32_1
  doi: 10.1016/j.ccr.2012.11.003
– ident: e_1_2_8_26_1
  doi: 10.1002/(SICI)1096-9896(199704)181:4<381::AID-PATH787>3.0.CO;2-I
– ident: e_1_2_8_19_1
  doi: 10.1371/journal.pone.0083244
– ident: e_1_2_8_2_1
  doi: 10.1038/nrc1409
– ident: e_1_2_8_5_1
  doi: 10.1074/jbc.M009984200
– ident: e_1_2_8_9_1
  doi: 10.1093/nar/gkq603
– ident: e_1_2_8_15_1
  doi: 10.1093/nar/gkn923
SSID ssj0006395
Score 2.3707712
Snippet MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been...
MALT lymphomas with API2(BIRC3)-MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been...
MALT lymphomas with API2(BIRC3)‐MALT1 translocation usually have an indolent clinical course and rarely transform into aggressive lymphoma, and there have been...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 517
SubjectTerms API2‐MALT1
Apoptosis
cell line
Chromosome translocations
Endoplasmic reticulum
Genetic transformation
Heavy chains
Immunoglobulins
Intestine
Lymphoma
MALT lymphoma
MALT1 inhibitor
microarray analysis
Mucosal-associated lymphoid tissue
Myc protein
Polymerase chain reaction
Tumor cell lines
Title Establishment and characterization of a MALT lymphoma cell line carrying an API2‐MALT1 translocation
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fgcc.22855
https://www.ncbi.nlm.nih.gov/pubmed/32348592
https://www.proquest.com/docview/2419448657
https://search.proquest.com/docview/2396853411
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50QfHiY31VV4niwUt1myZ94GlZd1VwZcE9eCtpknrRVvZx2Js_wd_oL3GS7lYWEQShhULTJmQymW-mnW8AzryMK6klc_2UCnRQFHcFDtgNpYeHQeyBLWL7GD48RdcdQ5NzNc-FKfkhqoCb0Qy7XxsFF-no8ps09FnKC0ojbhLM0Uuw6Rt-v9qF0fLykomAu7hmwzmrUJNeVk8u2qIfAHMRr1qD093411A3YX2GM0mrXBhbsKTzOqyUlSendVjtzb6pb0PWQYBoY1EmUEhEroisWJzLJE1SZESQXut-QF6mKP7iVRAT8SdmaESK4dAkS-GjpNW_o5_vH6apR8bGDhpjad6xA4NuZ9C-dWfVF1zJTAFHqakSPM4iqlKuYqHDVAaIxbnELSnOOBeKsRA9INFkOkibLKU8VamQeDZV5u9CLS9yvQ-Eci214ixE6MU8L44CpcMIkSHXgYwj5sDpXAzJW8mxkZRsyjTBqUvs1DnQmAsomanZKEH4EaN_GfDQgZPqNiqImQOR62KCbfw4QEyCHTuwVwq26sWnPot4TB04t_L7vfvkpt22Fwd_b3oIa9R45_aPtAbUxsOJPoLlkZoc27X6BSBT6hc
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTtwwEB6xVC1caLstkEJbt-qhl5SN48mPxGW1LAV1FyF1D71Fju1wgSxa2AM3HoFn5Ek64-ymQggJqVIiRYoTW54ZzzeTzGeAb1GF1jijwriUmgIUi6GmAYepiehgxJ74TWx_pyd_soMh0-TsL2thGn6INuHGluHXazZwTkjv_WMNPTPmh5QZYgdeqIQUkQs44tN2HSbfiw0XAYaktemSV6gn99pHH3qjRxDzIWL1Lufw9f8N9g1sLKCm6De68RZWXN2Fl83mkzddeDVefFZ_B9WQMKJPR3GuUOjaCtMSOTd1mmJaCS3G_dFEnN-QBkwvtOCkv-CxCaNnM66XokdF__RY3t_ecdNIXLMrZH_J73gPk8PhZHAULjZgCI3iPRyNk1ZjXmXSlmhz7dLSJATH0dCqlFeI2iqVUhCke8olZU-VEktbakNnz1bxJqzW09ptg5DojLOoUkJfKoryLLEuzQgcoktMnqkAvi7lUFw2NBtFQ6gsC5q6wk9dALtLCRULS7sqCIHkFGImmAbwpb1NNsJzoGs3nVObOE8IllDHAWw1km17iWWsMsxlAN-9AJ_uvvg5GPiLD89v-hnWjibjUTE6Pvm1A-uSg3X_g9ourF7P5u4jdK7s_JNX3L_yLu4_
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB6VrVhxgbI8mnZbDOLAJbBxPHmI02of7YpdtFL30Fvk2A6XNosW9sCtP4HfyC9h7OwGoQqpUqVEihQ7tjwezzfj-BuA06BArYwSfphzSQ6KRl9Sh_1YBXRZxB65JLY_4uufSX9gaXIu12dhKn6IOuBmNcOt11bBb3Vx8UIaeqPUOecJ4ga8FwTDLXF-GE7rZZhML1ZUBOjTpI3XtEIdflFXfW2M_kKYrwGrszjDnf_q6wfYXgFN1q1mxi68M2ULNqvUkw8taE5Wm-p7UAwIIbpglI0UMllqpmoa5-qUJpsXTLJJdzxjvx5I_vPfktmQP7NdY0ouFva0FFVl3emIP_15tEUDdm8NobWW9hv7MBsOZr3v_ir9gq-EzeCoDNcS0yLhOkedShPnKiIwjorWpLRAlFqImFwg2REmyjsi55jrXCq6O7oID6BRzkvzERhHo4xGERP2EkGQJpE2cULQEE2k0kR4cLIWQ3ZbkWxkFZ0yz2joMjd0HrTXAspWenaXEf5IycGMMPbguH5NGmLHQJZmvqQyYRoRKKGGPTisBFu3EvJQJJhyD86c_N5uPvvW67mHT_9e9Aia0_4wG4-urz7DFreeuvs7rQ2N-8XSfIGNO7386qbtMxlX7OU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Establishment+and+characterization+of+a+MALT+lymphoma+cell+line+carrying+an+API2%E2%80%90MALT1+translocation&rft.jtitle=Genes+chromosomes+%26+cancer&rft.au=Izumi%2C+Kiyotaka&rft.au=Nishikori%2C+Momoko&rft.au=Yuan%2C+Hepei&rft.au=Otsuka%2C+Yasuyuki&rft.date=2020-09-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1045-2257&rft.eissn=1098-2264&rft.volume=59&rft.issue=9&rft.spage=517&rft.epage=524&rft_id=info:doi/10.1002%2Fgcc.22855&rft.externalDBID=10.1002%252Fgcc.22855&rft.externalDocID=GCC22855
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1045-2257&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1045-2257&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1045-2257&client=summon